TECH insider filings
BIO-TECHNE Corp — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-03. Screen TECH transaction legs live →
Insider transaction summary — last 90 days
2026-08-23 to 2026-11-21, from the filings listed below: 16 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 50.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Kelderman Kim — Chief Executive Officer, Director | 2 | — | — | 11 |
| Hippel James — CFO | 2 | — | — | 10 |
| Bohnen Shane — SVP - General Counsel | 1 | — | — | 8 |
| Geist William — PRESIDENT, PROTEIN SCIENCES | 1 | — | — | 7 |
| BAUMGARTNER ROBERT V — Director | 2 | — | — | 4 |
| HIGGINS JOHN L — Director | 2 | — | — | 4 |
| Bushman Julie L — Director | 1 | — | — | 1 |
| Herr Amy E. — Director | 1 | — | — | 1 |
| KEEGAN JOSEPH D — Director | 1 | — | — | 1 |
| Klimovsky Judith V. — Director | 1 | — | — | 1 |
+2 more insiders in the window, not shown — every filing appears in the table below.
Recent insider filings — BIO-TECHNE Corp
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-03 | 4 | Hippel James — CFO | Option exercise (M): 11,545 @ $0 · Tax withholding (F): 5,096 @ $72.66 · Option exercise (M): 11,545 (derivative) @ $0 | EDGAR |
| 2026-11-03 | 4 | Kelderman Kim — Chief Executive Officer, Director | Tax withholding (F): 2,385 @ $72.66 | EDGAR |
| 2026-11-02 | 4/A | Hippel James — CFO | Option exercise (M): 9,980 @ $0 · Tax withholding (F): 4,423 @ $72.40 · Disposition to issuer (D): 34,443 (derivative) @ $0 · Option exercise (M): 1,067 (derivative) @ $0 · Disposition to issuer (D): 12,798 (derivative) @ $0 · Option exercise (M): 4,010 (derivative) @ $0 · +1 more | EDGAR |
| 2026-11-02 | 4/A | Kelderman Kim — Chief Executive Officer, Director | Option exercise (M): 21,736 @ $0 · Tax withholding (F): 10,955 @ $72.40 · Disposition to issuer (D): 22,044 (derivative) @ $0 · Disposition to issuer (D): 23,949 (derivative) @ $0 · Option exercise (M): 683 (derivative) @ $0 · Disposition to issuer (D): 8,190 (derivative) @ $0 · +4 more | EDGAR |
| 2026-11-02 | 4/A | Geist William — PRESIDENT, PROTEIN SCIENCES | Option exercise (M): 6,547 @ $0 · Tax withholding (F): 2,019 @ $72.40 · Disposition to issuer (D): 22,545 (derivative) @ $0 · Disposition to issuer (D): 698 (derivative) @ $0 · Option exercise (M): 8,376 (derivative) @ $0 · Option exercise (M): 2,623 (derivative) @ $0 · +1 more | EDGAR |
| 2026-11-02 | 4/A | Bohnen Shane — SVP - General Counsel | Option exercise (M): 4,420 @ $0 · Tax withholding (F): 1,366 @ $72.40 · Disposition to issuer (D): 11,929 (derivative) @ $0 · Option exercise (M): 370 (derivative) @ $0 · Disposition to issuer (D): 4,432 (derivative) @ $0 · Option exercise (M): 49 (derivative) @ $0 · +2 more | EDGAR |
| 2026-11-02 | 4 | Herr Amy E. — Director | Grant/award (A): 2,750 @ $0 | EDGAR |
| 2026-11-02 | 4 | Klimovsky Judith V. — Director | Grant/award (A): 2,750 @ $0 | EDGAR |
| 2026-11-02 | 4 | Seth Alpna — Director | Grant/award (A): 2,750 @ $0 | EDGAR |
| 2026-11-02 | 4 | Vessey Rupert — Director | Grant/award (A): 2,750 @ $0 | EDGAR |
| 2026-11-02 | 4 | HIGGINS JOHN L — Director | Grant/award (A): 2,750 @ $0 | EDGAR |
| 2026-11-02 | 4 | KEEGAN JOSEPH D — Director | Grant/award (A): 2,750 @ $0 | EDGAR |
| 2026-11-02 | 4 | BAUMGARTNER ROBERT V — Director | Grant/award (A): 2,750 @ $0 | EDGAR |
| 2026-11-02 | 4 | Bushman Julie L — Director | Grant/award (A): 2,750 @ $0 | EDGAR |
| 2026-09-30 | 4 | HIGGINS JOHN L — Director | Option exercise (M): 15,940 @ $0 · Tax withholding (F): 5,562 @ $72.51 · Option exercise (M): 15,940 (derivative) @ $0 | EDGAR |
| 2026-09-24 | 4 | BAUMGARTNER ROBERT V — Director | Option exercise (M): 15,940 @ $0 · Tax withholding (F): 5,559 @ $72.55 · Option exercise (M): 15,940 (derivative) @ $0 | EDGAR |
| 2026-08-19 | 4 | Crouse Steven C. — President - Diag & Spatial Bi | Grant/award (A): 8,702 (derivative) @ $0 · Grant/award (A): 14,140 (derivative) @ $0 | EDGAR |
| 2026-08-19 | 4 | Geist William — PRESIDENT, PROTEIN SCIENCES | Grant/award (A): 14,762 (derivative) @ $0 · Grant/award (A): 23,985 (derivative) @ $0 | EDGAR |
| 2026-08-19 | 4 | Herr Amy E. — Director | Grant/award (A): 1,381 (derivative) @ $0 | EDGAR |
| 2026-08-19 | 4 | Hippel James — CFO | Grant/award (A): 22,438 (derivative) @ $0 · Grant/award (A): 36,459 (derivative) @ $0 | EDGAR |
| 2026-08-19 | 4 | Kelderman Kim — Chief Executive Officer, Director | Grant/award (A): 57,590 (derivative) @ $0 · Grant/award (A): 93,582 (derivative) @ $0 | EDGAR |
| 2026-08-19 | 4 | Bohnen Shane — SVP - General Counsel | Grant/award (A): 11,344 (derivative) @ $0 · Grant/award (A): 18,432 (derivative) @ $0 | EDGAR |
| 2026-08-18 | 4 | Hippel James — CFO | Option exercise (M): 9,779 @ $0 · Tax withholding (F): 4,310 @ $72.40 · Option exercise (M): 866 (derivative) @ $0 · Disposition to issuer (D): 12,999 (derivative) @ $0 · Disposition to issuer (D): 34,982 (derivative) @ $0 · Option exercise (M): 4,010 (derivative) @ $0 · +1 more | EDGAR |
| 2026-08-18 | 4 | Kelderman Kim — Chief Executive Officer, Director | Option exercise (M): 21,470 @ $0 · Tax withholding (F): 10,821 @ $72.40 · Option exercise (M): 554 (derivative) @ $0 · Disposition to issuer (D): 8,319 (derivative) @ $0 · Disposition to issuer (D): 22,389 (derivative) @ $0 · Option exercise (M): 588 (derivative) @ $0 · +4 more | EDGAR |
| 2026-08-18 | 4 | Geist William — PRESIDENT, PROTEIN SCIENCES | Option exercise (M): 6,416 @ $0 · Tax withholding (F): 1,976 @ $72.40 · Option exercise (M): 567 (derivative) @ $0 · Disposition to issuer (D): 8,507 (derivative) @ $0 · Disposition to issuer (D): 22,898 (derivative) @ $0 · Option exercise (M): 2,623 (derivative) @ $0 · +1 more | EDGAR |
| 2026-08-18 | 4 | Bohnen Shane — SVP - General Counsel | Option exercise (M): 4,350 @ $0 · Tax withholding (F): 1,343 @ $72.40 · Option exercise (M): 49 (derivative) @ $0 · Disposition to issuer (D): 12,117 (derivative) @ $0 · Option exercise (M): 300 (derivative) @ $0 · Disposition to issuer (D): 4,502 (derivative) @ $0 · +2 more | EDGAR |
| 2026-08-18 | 4 | Herr Amy E. — Director | Option exercise (M): 589 @ $0 · Tax withholding (F): 213 @ $72.40 · Option exercise (M): 118 (derivative) @ $0 · Option exercise (M): 160 (derivative) @ $0 · Option exercise (M): 311 (derivative) @ $0 | EDGAR |
| 2026-08-18 | 4 | Crouse Steven C. — President - Diag & Spatial Bi | Option exercise (M): 5,423 @ $0 · Tax withholding (F): 1,947 @ $72.40 · Option exercise (M): 1,379 (derivative) @ $0 · Option exercise (M): 1,868 (derivative) @ $0 · Option exercise (M): 2,176 (derivative) @ $0 | EDGAR |
| 2026-07-31 | 4 | Hippel James — CFO | Option exercise (M): 62,068 @ $47.60 · Tax withholding (F): 51,024 @ $72.03 · Option exercise (M): 62,068 (derivative) @ $0 | EDGAR |
| 2026-07-30 | 4 | Kelderman Kim — Chief Executive Officer, Director | Option exercise (M): 35,000 @ $47.60 · Tax withholding (F): 28,686 @ $72.07 · Option exercise (M): 35,000 (derivative) @ $0 | EDGAR |
| 2026-07-27 | 4 | Bohnen Shane — SVP - General Counsel | Option exercise (M): 448 @ $47.60 · Tax withholding (F): 344 @ $71.77 · Option exercise (M): 448 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | Crouse Steven C. — President - Diag & Spatial Bi | Option exercise (M): 600 · Tax withholding (F): 216 @ $49.77 · Option exercise (M): 600 (derivative) @ $0 | EDGAR |
| 2026-05-12 | 4 | Herr Amy E. — Director | Option exercise (M): 6,636 @ $47.60 · Sale (S): 6,636 @ $48.28 · Option exercise (M): 6,636 (derivative) @ $0 | EDGAR |
| 2026-05-07 | 4 | Bohnen Shane — SVP - General Counsel | Option exercise (M): 8,400 @ $47.60 · Tax withholding (F): 7,055 @ $56.68 · Option exercise (M): 8,400 (derivative) @ $0 | EDGAR |
| 2026-05-07 | 4 | Kelderman Kim — Chief Executive Officer, Director | Option exercise (M): 26,692 @ $47.60 · Tax withholding (F): 23,951 @ $56.68 · Option exercise (M): 26,692 (derivative) @ $0 | EDGAR |
| 2026-05-07 | 4 | Hippel James — CFO | Option exercise (M): 62,000 @ $47.60 · Tax withholding (F): 56,955 @ $56.68 · Option exercise (M): 62,000 (derivative) @ $0 | EDGAR |
| 2026-05-05 | 4 | Crouse Steven C. — President - Diag & Spatial Bi | Option exercise (M): 794 · Tax withholding (F): 311 @ $55.02 · Option exercise (M): 794 (derivative) @ $0 | EDGAR |
| 2026-04-24 | 4 | Kelderman Kim — Chief Executive Officer, Director | Option exercise (M): 11,344 @ $0 · Tax withholding (F): 1,363 @ $58.58 · Option exercise (M): 11,344 (derivative) @ $0 | EDGAR |
| 2026-04-24 | 4 | Hippel James — CFO | Option exercise (M): 62,000 @ $0 · Tax withholding (F): 56,097 @ $58.58 · Option exercise (M): 62,000 (derivative) @ $0 | EDGAR |
| 2026-04-16 | 4 | Kelderman Kim — Chief Executive Officer, Director | Option exercise (M): 36,500 @ $0 · Tax withholding (F): 32,088 @ $58.66 · Option exercise (M): 36,500 (derivative) @ $0 | EDGAR |
| 2026-04-07 | 4 | Bohnen Shane — SVP - General Counsel | Option exercise (M): 2,259 @ $0 · Tax withholding (F): 740 @ $53.13 · Option exercise (M): 2,259 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Crouse Steven C. — President - Diag & Spatial Bi | Grant/award (A): 2,387 (derivative) @ $0 · Grant/award (A): 735 (derivative) @ $0 · Grant/award (A): 1,911 (derivative) @ $0 | EDGAR |
| 2026-02-19 | 4 | Herr Amy E. — Director | Sale (S): 1,976 @ $59.10 | EDGAR |
| 2026-02-05 | 4 | Herr Amy E. — Director | Option exercise (M): 38 @ $0 · Tax withholding (F): 16 @ $64.63 · Option exercise (M): 38 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | McManus Matthew — President - Diag & Spatial Bio | Option exercise (M): 4,621 @ $0 · Tax withholding (F): 1,665 @ $64.09 · Option exercise (M): 4,621 (derivative) @ $0 | EDGAR |
| 2025-11-05 | 4 | Geist William — PRESIDENT, PROTEIN SCIENCES | Option exercise (M): 9,911 @ $0 · Tax withholding (F): 4,520 @ $62.57 · Option exercise (M): 9,911 (derivative) @ $0 | EDGAR |
| 2025-11-05 | 4 | Kelderman Kim — Chief Executive Officer, Director | Tax withholding (F): 2,303 @ $62.57 | EDGAR |
| 2025-11-05 | 4 | Hippel James — CFO | Option exercise (M): 13,159 @ $0 · Option exercise (M): 11,545 @ $0 · Tax withholding (F): 11,865 @ $62.57 · Option exercise (M): 13,159 (derivative) @ $0 · Option exercise (M): 11,545 (derivative) @ $0 | EDGAR |
| 2025-11-03 | 4 | BAUMGARTNER ROBERT V — Director | Grant/award (A): 1,640 @ $0 · Grant/award (A): 3,777 (derivative) @ $0 | EDGAR |
| 2025-11-03 | 4 | HIGGINS JOHN L — Director | Grant/award (A): 1,640 @ $0 · Grant/award (A): 3,777 (derivative) @ $0 | EDGAR |
Recent 8-K events — BIO-TECHNE Corp
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-04 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-23 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-14 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-08-12 | 8-K | 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-26 | 8-K | 1.01 — Entry into a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-25 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-06 | 8-K | 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-11 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-04 | 8-K | 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-05 | 8-K | 2.02 — Results of Operations and Financial Condition 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
GET https://api.filingpulse.io/v1/insider-trades?ticker=TECH returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs